Announcements
Zepbound: Now Prescribing at JourneyLite!
Zepbound is available now! Zepbound, the newest injectable weight-loss medication just approved by the FDA, is based on the diabetes medication Mounjaro. The generic…
Read article
Education topic
ozempic
JourneyLite guidance, explanations, and practical resources about ozempic.
Keep exploring
Browse another topic
Article library
View all articles
ozempic
Announcements
Zepbound versus Wegovy: Zepbound (tirzepatide) superior to Wegovy (semaglutide) in early study
Zepbound versus Wegovy: Which one is better? GLP-1 receptor agonists (GLP-1 RA's) are newer medications that were initially released as treatment for diabetes In…
Read article
Announcements
Wegovy Costs and Compounded Semaglutide: What Has Changed
Understand what changed after the semaglutide injection shortage, how compounded drugs differ, and what to ask about Wegovy coverage and treatment costs.
Read article
Education
GLP-1 Receptor Agonists vs. Weight Loss Surgery: 5 Things You Should Know (Wegovy/Ozempic/Mounjaro)
By Dr. Trace Curry Dr. Curry is the medical director of JourneyLite Surgery Center and JourneyLite Physicians in Cincinnati, Ohio. What are GLP-1 Receptor…
Read articleNeed an individualized answer?
Turn what you learned into a plan.
A JourneyLite provider can help you compare treatment options based on your health, goals, coverage, and preferences.